StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Silo Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Silo Pharma's pe ratio was 1.9× on Oct 31, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Oct 31, 20221.9×−1.4
2021Dec 31, 20213.3×–

More Silo Pharma figures

See a number that looks wrong?